Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Weight Verification of Dispensed Materials – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Weight Verification of Dispensed Materials – V 2.0

Standard Operating Procedure for Weight Verification of Dispensed Materials in Sterile Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/007/2025
Supersedes SOP/SIM/007/2022
Page No. Page 1 of 13
Issue Date 17/06/2025
Effective Date 19/06/2025
Review Date 17/06/2026

1. Purpose

To establish a standardized procedure for verifying the weight of all raw materials dispensed for sterile injectable manufacturing. This SOP ensures that weights

recorded are accurate, validated, and consistent with GMP requirements, thereby preventing batch failures and deviations.

2. Scope

This SOP applies to all raw materials dispensed for sterile injectable products where weight verification is required prior to batch charging. The process includes independent verification, documentation, and reconciliation of dispensed quantities.

3. Responsibilities

  • Stores Chemist: Performs initial weighing and records preliminary weights.
  • QA Executive: Independently verifies the weights and signs the verification log.
  • Production Pharmacist: Cross-checks dispensed material against the BMR before charging.
  • QC Analyst: Verifies weight accuracy where analytical verification is required.
See also  Sterile Injectable Manufacturing: SOP for Cross-Verification of In-Process Data - V 2.0

4. Accountability

The Head of QA is accountable for ensuring that no material proceeds to production without verified weights and proper documentation as per this SOP.

5. Procedure

5.1 Preparation and Review

  1. Receive MRN and approved BMR from the production department.
  2. Ensure all dispensed containers are properly labeled with gross weight, tare weight, and net weight.
  3. Check that weighing was performed using calibrated balances.

5.2 Independent Weight Verification

  1. QA shall reweigh the container using the same balance or a qualified equivalent in the same area.
  2. Verify that the net weight recorded is within the specified tolerance of ±0.1%.
  3. Confirm container ID, material name, batch number, and reconcile labels.
  4. Sign and date the Weight Verification Log (Annexure-1) immediately after confirmation.

5.3 Recording and Cross-Verification

  1. Document the gross weight, tare weight, and net weight as observed by QA.
  2. Attach weight verification log to the dispensing record set for QA filing.
  3. Production pharmacist shall countersign upon receipt of verified materials.
See also  Sterile Injectable Manufacturing: SOP for Formulation Development of Subcutaneous Injections - V 2.0

5.4 Handling Discrepancies

  1. If weight difference exceeds ±0.1%, investigate possible root cause (e.g., label error, balance drift).
  2. Initiate a deviation report and inform QA Manager for further evaluation.
  3. Repeat dispensing and verification if required after corrective action.

5.5 Documentation Requirements

  1. Ensure all entries in the weight verification log are legible, traceable, and signed with full name and date.
  2. Corrections must follow ALCOA+ principles and be justified in a footnote.
  3. Retain all weight verification logs as part of the batch record file.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • MRN: Material Requisition Note
  • ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

  1. Weight Verification Log – Annexure-1
  2. Material Dispensing Record – Annexure-2
  3. Deviation Report Form (if applicable) – Annexure-3

8. References

  • WHO TRS 986 – Good Manufacturing Practices
  • ICH Q9 – Quality Risk Management
  • Schedule M – Indian GMP
See also  Sterile Injectable Manufacturing: SOP for Validation of Analytical Testing Methods - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Store Chemist QA Executive Head – Quality Assurance
Department Warehouse Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Weight Verification Log

Date Material Batch No. Gross (g) Tare (g) Net (g) Verified By
17/06/2025 Mannitol BN-MAN1025 1025.0 25.0 1000.0 Sunita Reddy

Annexure-2: Material Dispensing Record

Material Name Batch No. Qty Required Qty Dispensed Dispensed By Date
Mannitol BN-MAN1025 1000 g 1000 g Rajesh Kumar 17/06/2025

Annexure-3: Deviation Report Form

Date Reference No. Discrepancy Observed Root Cause Corrective Action Approved By
17/06/2025 DEV-025 Weight mismatch Labeling Error Re-weighing and retraining QA Head

Revision History

Revision Date Revision No. Details Reason Approved By
20/01/2022 1.0 Initial release GMP Requirement QA Head
17/06/2025 2.0 Enhanced ALCOA compliance and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Setting Up Filling Machines for Gels – V 2.0
Next Post: Analytical Method Development: Thermal Stability Analysis using GC – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version